Clinical trial
Safety of Treatment of Uterine Fibroids With Asoprisnil
NCT00156208 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00156208 |
|---|---|
| Title | Safety of Treatment of Uterine Fibroids With Asoprisnil |
| Official title | A Phase III, 18-Month, Extension Study to Evaluate the Safety of Asoprisnil in Subjects With Uterine Leiomyomata |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Fibroid Uterus, Leiomyoma, Menorrhagia, Metrorrhagia, Uterine Fibroids |
| Intervention type | Drug |
| Interventions | Asoprisnil |
| Enrollment | 166 |
| Start date | Apr 1, 2004 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | May 29, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: